Cited by 90Chronic Kidney Disease and DiabetesDiabetes Management and ResearchDialysis and Renal Disease Management

Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease

Freedman, Barry I., Shihabi, Zak K., Andries, Lilian, Cardona, Cesar Y., Peacock, Todd P., Byers, Joyce R., Russell, Gregory B., Stratta, Robert J. +1 more·2010·American Journal of Nephrology

Abstract

Background Relative to hemoglobin A(1c) (HbA(1c)), glycated albumin (GA) more accurately reflects recent glycemic control in diabetic patients on hemodialysis and peritoneal dialysis. These assays have yet to be compared in patients with advanced chronic kidney disease (CKD). Methods HbA(1c) and GA were simultaneously measured in 303 diabetic subjects: 70 with CKD prior to dialysis (CKD-stage 4), 184 with CKD after transplantation (TXP-stage 3) and 49 non-nephropathy controls. Results Mean estimated GFR was 76, 46 and 26 ml/min in controls, TXP-3 and CKD-4 cases, respectively. Mean (SD) HbA(1c) (%) and GA (%) concentrations were 7.30 (1.40) and 16.8 (4.9) in controls, 7.28 (1.66) and 21.5 (6.4) in CKD-4 cases, and 7.21 (1.62) and 21.2 (5.5) in TXP-3 cases, respectively. The GA:HbA(1c) ratio differed significantly between non-nephropathy controls and both groups of CKD patients (both p Conclusions The relationship between glycated albumin and HbA(1c) is influenced by the presence of reduced GFR in diabetic patients with CKD. The accuracy of the HbA(1c) assay in diabetic subjects with severe nephropathy requires further investigation, although HbA(1c) performs relatively well with milder CKD.

Integrity signals

Registry

Crossref · 10.1159/000287561

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In observational studies, glycated albumin is associated with all-cause and cardiovascular mortality in patients treated by chronic hemodialysis.

    “In observational studies, glycated albumin is associated with all-cause and cardiovascular mortality in patients treated by chronic hemodialysis.”
  • Correlations of fructosamine with HbA1c and mean blood glucose were examined in 4 observational studies.

    “Correlations of fructosamine with HbA1c and mean blood glucose were examined in 4 observational studies.”
  • Accuracy and precision of HbA1c measurement declines with advanced CKD (G4-G5), particularly among patients treated by dialysis, in whom HbA1c measurements have low reliability.

    “Practice Point 2.1.2: Accuracy and precision of HbA1c measurement declines with advanced CKD (G4 -G5), particularly among patients treated by dialysis, in whom HbA1c measurements have low reliability.”
  • Correlations of directly measured blood glucose levels with HbA1c, glycated albumin, and fructosamine were progressively weaker with advanced CKD stages (G4-G5), especially kidney failure treated by dialysis.

    “Correlations of directly measured blood glucose levels with 3 glycemic biomarkers -HbA1c, glycated albumin, and fructosamine -were progressively weaker with advanced CKD stages (G4 -G5), especially kidney failure treated by dialysis. 196,197,205,210,227”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Freedman, B. I., Shihabi, Z. K., Andries, L., Cardona, C. Y., Peacock, T. P., Byers, J. R., Russell, G. B., Stratta, R. J., & Bleyer, A. J.
Affiliations
Wake Forest University Health Sciences (US)
Venue
American Journal of Nephrology
Publisher
S. Karger AG
Published
2010
Volume
31
Issue
5
Pages
375-379
ISSN
  • 0250-8095 (ISSN-L)
  • 1421-9670
OpenAlex
W1975180120
Cited by
90
References
2
Citations by year
2026: 3 · 2024: 6 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 9 · 2019: 3 · 2018: 7 · 2017: 7 · 2016: 10 · 2015: 8 · 2014: 6 · 2013: 3 · 2012: 8
FWCI
5.23
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Nephrology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
Keywords
glycated albumin, HbA1c, glycemic control, diabetic nephropathy, advanced chronic kidney disease, estimated glomerular filtration rate, dialysis, kidney transplantation, glycemic markers
MeSH terms
Glycated Serum Albumin, Aged, Diabetes Mellitus, Female, Glomerular Filtration Rate, Glycated Hemoglobin, Humans, Hyperglycemia, Hypoglycemic Agents, Kidney Failure, Chronic, Male, Middle Aged, Models, Biological, Serum Albumin, Kidney Transplantation, Glycation End Products, Advanced, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review